FDA is advancing new efforts to address drug shortages

FDA

19 November 2018 - A key component of our public health mission is to help ensure Americans have access to safe and effective medicines. 

That’s why, as drug shortages arise, the FDA takes immediate action within our authorities, working across the FDA and with other government agencies, industry, and other stakeholders, to minimise the impact of these shortages and maintain or restore availability of critical medicines for the patients who need them.

A shortage of even one critical drug can have a significant effect on U.S. patients‘ health. So many of our efforts are focused on preventing shortages in the first place. But when shortages arise, we must also focus on identifying the root cause, and on taking steps to help make sure similar circumstances don’t happen again. The lessons we learn help us inform and improve our efforts to prevent shortages in the future.

Read FDA statement

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Regulation , Supply